Dec. 16, 2024 — A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. Researchers have discovered that an ...

Muscular dystrophy, loss of mobility ... be taken to support better nutrition with this disease. People with DMD face a number of challenges to their nutritional health, including both over ...

The federal government has funded more than a billion dollars in biomedical and public health research at Maine institutions ...

New research led by the University of Portsmouth has revealed how Duchenne muscular dystrophy (DMD), best known for causing severe muscle degeneration, also profoundly affects the brain ...

Colton Belluzzo was diagnosed with a form of muscular dystrophy when he was a baby. The disease has weakened his muscles over time. But he and his family now have good reason to be optimistic.

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...

The study uncovers the molecular 'rules' driving the arrangement of emerin into nanoclusters and the mechanisms leading to their defective assembly in people with muscular dystrophy. A new ...

The 11-year-old's strength and bravery in living with the impact of the serious muscle-wasting condition was hailed by her ...

Patients with myotonic dystrophy face unique challenges in managing their ... 1-2 Recent studies presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference shed ...

Convener of Stirling Council’s Children and Young People Committee, Cllr Danny Gibson said: “Somhairle’s bravery, inner ...